Platelet-activating factor antagonist-based intensive antiplatelet strategy in acute ischemic stroke: A propensity score matched with network pharmacology analysis
CONCLUSIONS: An intensive antiplatelet strategy of DGMI plus traditional antiplatelet agents is effective in treating AIS and may work by mediating post-stroke inflammation and thrombosis.PMID:37435773 | DOI:10.1111/cns.14331
Source: CNS Neuroscience and Therapeutics - Category: Neuroscience Authors: Xiaoyan Han Youjia Li Xuemin Chen Dong Pan Junning Mo Jiaming Qiu Yi Li Yan Chen Yan Huang Qingyu Shen Yamei Tang Source Type: research
More News: Bleeding | Brain | Drugs & Pharmacology | Genetics | Ischemic Stroke | Neurology | Neuroscience | Stroke | Study | Thrombosis